Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study
M. Dell'ova, E. De Maio, S. Guiu, L. Roca +6 more
2015BMC Cancer43 citations Open access
Semantic Scholar

